<?xml version="1.0" encoding="UTF-8"?>
<p>Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory disorder that primarily involves synovial joints 
 <xref rid="sct312331-bib-0001" ref-type="ref">1</xref>. During the past decade, new classes of disease‐modifying antirheumatic drugs (DMARDs) and updated treatment strategies enabled better clinical outcomes for RA patients, but few patients reach long‐term drug‐free clinical remission despite such achievements. Moreover, these approaches are costly and may ensue side effects, for instance, laboratory test abnormalities and serious infections 
 <xref rid="sct312331-bib-0002" ref-type="ref">2</xref>, 
 <xref rid="sct312331-bib-0003" ref-type="ref">3</xref>. Therefore, the need still exists for an effective and safe treatment for those who respond inadequately to current therapies.
</p>
